Randomized controlled open label trial on the use of favipiravir combined with inhaled interferon beta-1b in hospitalized patients with moderate to severe COVID-19 pneumonia

OBJECTIVE: To evaluate the therapeutic effectiveness of favipiravir combined with inhaled interferon beta-1b in adult patients hospitalized with moderate to severe COVID-19 pneumonia. METHODS: A randomized, open-label controlled trial of oral favipiravir in adults hospitalized with moderate to sever...

Descripción completa

Detalles Bibliográficos
Autores principales: Khamis, Faryal, Al Naabi, Hanan, Al Lawati, Adil, Ambusaidi, Zaiyana, Al Sharji, Mariam, Al Barwani, Umkulthum, Pandak, Nenad, Al Balushi, Zakariya, Al Bahrani, Maher, Al Salmi, Issa, Al-Zakwani, Ibrahim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833906/
https://www.ncbi.nlm.nih.gov/pubmed/33181328
http://dx.doi.org/10.1016/j.ijid.2020.11.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833906/
https://www.ncbi.nlm.nih.gov/pubmed/33181328
http://dx.doi.org/10.1016/j.ijid.2020.11.008

Ejemplares similares